Routine screening for Coxiella burnetii infection during pregnancy:a clustered randomised controlled trial during an outbreak, the Netherlands, 2010
Between 2007 and 2010, the Netherlands experienced one of the largest outbreaks of Q fever. Since asymptomatic Coxiella burnetii infection has been associated with maternal and obstetric complications, evidence about the effectiveness of routine screening during pregnancy in outbreak areas is needed. We performed a clustered randomised controlled trial during the Dutch outbreak, in which 55 midwife centres were randomised to recruit pregnant women for an intervention or control strategy. In both groups a serum sample was taken between 20 and 32 weeks of gestation. In the intervention group (n=... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2013 |
Reihe/Periodikum: | Munster , J M , Leenders , A C , Hamilton , C J , Meekelenkamp , J C , Schneeberger , P M , van der Hoek , W , Rietveld , A , de Vries , E , Stolk , R P , Aarnoudse , J G & Hak , E 2013 , ' Routine screening for Coxiella burnetii infection during pregnancy : a clustered randomised controlled trial during an outbreak, the Netherlands, 2010 ' , Eurosurveillance , vol. 18 , no. 24 , pp. 14-23 . |
Schlagwörter: | Q-FEVER / WOMEN / DIAGNOSIS / SEROPREVALENCE / ANTIBODIES / EPIDEMIC / OUTCOMES / HISTORY / FRANCE / TERM |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29192490 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/d38f2fc1-1daf-4f9f-a5ca-726e0525197a |
Between 2007 and 2010, the Netherlands experienced one of the largest outbreaks of Q fever. Since asymptomatic Coxiella burnetii infection has been associated with maternal and obstetric complications, evidence about the effectiveness of routine screening during pregnancy in outbreak areas is needed. We performed a clustered randomised controlled trial during the Dutch outbreak, in which 55 midwife centres were randomised to recruit pregnant women for an intervention or control strategy. In both groups a serum sample was taken between 20 and 32 weeks of gestation. In the intervention group (n=536), the samples were analysed immediately by indirect immunofluorescence assay for the presence of IgM and IgG (phase I/II) and treatment was given during pregnancy in case of an acute or chronic infection. In the control group (n=693), sera were frozen for analysis after delivery. In both groups 15% were seropositive. In the intervention group 2.2% of the women were seropositive and had an obstetric complication, compared with 1.4% in the control group (Odds ratio: 1.54 (95% confidence interval 0.60-3.96)). During a large Q fever outbreak, routine C. burnetii screening starting at 20 weeks of gestation was not associated with a relevant reduction in obstetric complications and should therefore not be recommended.